Annual Meeting Agenda

What Can Our Society Do for You in 2026 and Beyond?

Presenter: Michael Berry, MD, FACS

Coding and Reimbursement Symposium

Moderators: Richard Fine, MD, FACS; Walton Taylor, MD, FACS

Introductions and Updates
Walton Taylor, MD, FACS
Importance of Diagnostic Codes
Carinne Anderson, MD, FACS
How Do I Code This?
Richard Fine, MD, FACS; Walton Taylor, MD, FACS
Q&A

Artificial Intelligence Applications

Moderators: Carissia Calvo-Strube, MD, FACS; Susan Hoover, MD, FACS

Welcome and Introduction
Carissia Calvo-Strube, MD, FACS; Susan Hoover, MD, FACS
AI and Breast Imaging
Lily Lai, MD, FACS
AI and Pathology
Anil Parwani, MD
AI and Note Taking- Claude/Plaude/Dax
Roshni Rao, MD, FACS
Q&A

Paradigm Changes in Therapy

Moderators: E. Shelley Hwang, MD, MPH, FACS; Puneet Singh, MD, FACS

Welcome and Introduction
E. Shelley Hwang, MD, MPH, FACS; Puneet Singh, MD, FACS
Neoadjuvant Radiation
Asal Rahimi, MD, MS
Neoadjuvant Cryoablation
A. Marilyn Leitch, MD, FACS
Omission of Surgery with Image Guided Biopsy Assessment of pCR
Henry Kuerer, MD, PhD, FACS
Q&A

Scientific Oral Presentations I

Moderators: Doreen Agnese, MD, FACS; Tina Hieken, MD, FACS

A Prospective, Multi-Center Randomized Controlled Trial (RCT) of the da Vinci SP® Surgical System vs Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer
Katherine Kopkash, MD, FACS
Impact of Axillary Surgery Omission Under SOUND, INSEMA, and Choosing Wisely Criteria on CDK4/6 Inhibitor Eligibility in HR+/HER2– Breast Cancer
Austin Williams, MD, MSEd, FACS
Increase in Non-Guideline Concordant De-Implementation of Axillary Lymph Node Dissection
Anna Louie, MD
Targeted multidisciplinary continuous improvement process reduces time to breast cancer surgery with immediate reconstruction
Pooja Varman, MD
Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy
Jennifer Tseng, MD

Intersociety Roundtable

Moderator: Susan Boolbol, MD, FACS

Welcome and Introduction
Susan Boolbol, MD, FACS
SBI
Peter Eby, MD, FSBI, FACR
ASTRO
Sameer Keole, MD, FASTRO
ASCO
Elizabeth Mittendorf, MD, PhD, MHCM, FACS
ASBrS
Michael Berry, MD, FACS
Roundtable Discussion
Susan Boolbol, MD, FACS; Peter Eby, MD, FSBI, FACR; Sameer Keole, MD, FASTRO; Elizabeth Mittendorf, MD, PhD, MHCM, FACS
Q&A

Presidential Address

Welcome and Introduction
Eric Manahan, MD, MBA, FACS
“Thank Y’all”
Michael Berry, MD, FACS

DEBATE! Is There a Role for Local Therapy in Stage IV Disease?

Moderators: Eric Manahan, MD, MBA, FACS; Jennifer Plichta, MD, MS, FACS

Welcome and Introduction
Eric Manahan, MD, MBA, FACS; Jennifer Plichta, MD, MS, FACS
Operate for Stage IV Breast Cancer
Jamie Wagner, DO, MBA, FACOS, FACS
Do not Operate for Stage IV Breast Cancer
Kelly Hunt, MD, FACS

DEBATE! Is There a Role for HRT in Breast Cancer/High-risk Patients?

Moderators: Fedra Fallahian, MD; A. Marilyn Leitch, MD, FACS

Welcome and Introduction
Fedra Fallahian, MD; A. Marilyn Leitch, MD, FACS
Yes
Kristin Rojas, MD, FACS, FACOG
No
Melissa Pilewskie, MD, FACS

DEBATE! PMRT in 1-3 Sentinel Lymph Nodes

Moderators: Susan Boolbol, MD, FACS; Armando Giuliano, MD, FACS

Welcome and Introduction
Susan Boolbol, MD, FACS; Armando Giuliano, MD, FACS
Yes
Asal Rahimi, MD, MS
No
Mehran Habibi, MD, MBA, FACS

Unpacking Genomics

Moderators: Lillian Erdahl, MD, FACS; Kelly Hunt, MD, FACS

Welcome and Introduction
Lillian Erdahl, MD, FACS; Kelly Hunt, MD, FACS
ISPY-2: How Close are we to Personalized Care?
Rita Mukhtar, MD, FACS
What to Know About MRD
Laura Rosenberger, MD, MS, FACS
Review of Genomic Tests for Breast Cancer
William Gradishar, MD
Q&A

Multidisciplinary Perspectives in De-escalation

Moderators: Lily Gutnik, MD, MPH, FACS; Laura Kruper, MD, FACS

Welcome and Introduction
Lily Gutnik, MD, MPH, FACS; Laura Kruper, MD, FACS
How Omission of Axillary Surgery Impacts Radiation
Asal Rahimi, MD, MS
How Omission of Axillary Surgery Impacts Systemic Therapy
William Gradishar, MD
Current De-escalation Recommendations
Carla Fisher, MD, MBA, FACS
Q&A

Scientific Oral Presentations II

Moderators: Zahraa Al-Hilli, MD, MBA, FACS, FRCSI; Eli Avisar, MD, FACS

Lymphovascular Invasion in SOUND-eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis
Thomas Amburn, MD
Prospective Clinical Trial on Expanding the Eligibility Criteria for Targeted Axillary Dissection after Neoadjuvant Systemic Therapy in Breast Cancers with Advanced Nodal Disease
Andrea Lee, MD
Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma: Report from the largest single institutional analysis
Genevieve Fasano, MD
Impact of Omission of Sentinel Lymph Node Surgery on Radiation Treatment in Patients Age 50 and Older with Breast Cancer Treated with Lumpectomy: A Single-Institution Retrospective Review
Matthew Hager, MD
Does locoregional treatment in non-progressive De novo metastatic breast cancer improve overall survival? A randomized controlled trial
Mahtab Vasigh, MD
Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and Axilla
Lucia Castro Hernandez, MD

Hoag Hospital Surgical Innovation Forum: Innovative Surgical Techniques

Moderators: Sadia Khan, DO, FACS, FACOS; Katharine Schulz-Costello, DO

Welcome and Introduction
Sadia Khan, DO, FACS, FACOS; Katharine Schulz-Costello, DO
Free Flap Breast Reconstruction: Beyond the DIEP
Nicholas Haddock, MD
Robotic Mastectomy
Arnold Hill, MCh, FRCSI, FACS
Lympho-venous Bypass
Zahraa Al-Hilli, MD, MBA, FACS, FRCSI
Nerve Re-anastomosis for Sensation
Anne Peled, MD
Q&A

Quickshot Presentations

Moderators: Sarah Blair, MD, FACS; Mary Mrdutt, MD, MS, FACS

Is it time to redefine clinical nodal staging for breast cancer?
Pooja Varman, MD
Timing of Surgical Axillary Staging and Impact on Effectiveness of Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection
Helen Johnson, MD
Is mastectomy necessary in patients with occult breast cancer and advanced (N2/N3) nodal disease?
Courtney Lattimore, MD
Nodal Pathologic Response After Neoadjuvant Systemic Therapy in Clinically Advanced Node-Positive (cN2 and cN3) Breast Cancer
Diana Jaen, MD
Effect of Breast Cancer and Antibiotic Duration on the Microbiome and Outcomes After Implant-Based Breast Reconstruction
Alexandra Lopes
A Prospective, Multicenter Investigation of the da Vinci Surgical System in Prophylactic Nipple Sparing Mastectomy Procedures
Mara Piltin, DO, FACS
Extended Follow-Up of Trimodality Therapy Demonstrates Durable Disease Control for Radiation-Associated Angiosarcoma of the Breast
Saskia Leonard, MD
Preoperative vs Postmastectomy Radiotherapy in Immediate DIEP Breast Reconstruction: CAPPELLA Trial Interim Analysis
Shuang Hao, MD

Best Papers

Best Papers
Helen Pass, MD, FACS

"How I Do It" Videos

Moderators: Janie Grumley, MD, FACS; Courtney Vito, MD, FACS

Welcome and Introduction
Janie Grumley, MD, FACS; Courtney Vito, MD, FACS
Wise Pattern Skin Reduction Mastectomy and Reconstruction with Free Nipple Grafting
Rong Tang, MD
Endoscopic nipple sparing mastectomy
Paula Escobar, MD
Flattening the Curve A Method to Minimize Concavity after Total Mastectomy
Kristin Lupinacci, DO
Oncoplastic Breast Conserving Surgery for a Second Primary Cancer in a Patient With Prior Oncoplastic Breast Conservation
Samantha Lloy, MD
S.H.I.F.T. Oncoplasty - Simultaneous Hybrid Integration of Flap and Tissue Transposition
Jenna Capuano, DO

Breast Cancer and Lifestyle

Moderators: David Brenin, MD, FACS; Jennifer Gass, MD, FACS

Welcome and Introduction
David Brenin, MD, FACS; Jennifer Gass, MD, FACS
Diet and Cancer Care
Richard Gilmore, MD, MBA, FACS
Benefits and Data on Exercise
Jay Harness, MD, FACS
Integrative Medicine in Breast Cancer Survivorship
Danielle Jacobbe, DO
Q&A

Commonly Asked Questions: What Is the Data?

Moderators: Kristalyn Gallagher, DO, FACOS, FACS; Brigid Killelea, MD, MPH, FACS

Welcome and Introduction
Kristalyn Gallagher, DO, FACOS, FACS; Brigid Killelea, MD, MPH, FACS
GLP-1s and Breast Cancer
Giacomo Montagna, MD, MPH, FACS
Time to Treatment?
Shawna Willey, MD, FACS
How Do I Decide? Medical Decision Making
Heather Neuman, MD, FACS
Q&A

Medical Oncology Trials You Should Know About

Moderators: Judy Boughey, MD, FACS; Veronica Jones, MD, FACS

Welcome and Introduction
Judy Boughey, MD, FACS; Veronica Jones, MD, FACS
Breast Cancer Vaccinees
Nora Disis, MD
Immunotherapy Updates
Heather McArthur, MD, MPH, FASCO
Oral Combinations for ER+ Disease
William Gradishar, MD
Q&A

San Antonio, NCCN, and SSO Meeting Summaries

Moderators: Akiko Chiba, MD, FACS; Nora Hansen, MD, FACS

Welcome and Introduction
Akiko Chiba, MD, FACS; Nora Hansen, MD, FACS
San Antonio
Judy Boughey, MD, FACS
NCCN
William Gradishar, MD
SSO
Frederick Dirbas, MD
Q&A

Benign Disease

Moderators: Chandler Cortina, MD, MS, FACS; Faina Nakhlis, MD, FACS

Welcome and Introduction
Chandler Cortina, MD, MS, FACS; Faina Nakhlis, MD, FACS
Atypia and When to Excise
Amanda Amin, MD, MS, FACS
Idiopathic Granulomatous Mastitis, SMOLD
Stephanie Serres, MD, PhD
Fibroadenomas to Phyllodes
Heather Lillemoe, MD, FACS
Other Benign Lesions
Cory Donovan, MD
Q&A

Genetic Testing Guidelines and Clinical Management

Moderators: Carinne Anderson, MD, FACS; Kevin Hughes, MD, FACS

Welcome and Introduction
Carinne Anderson, MD, FACS; Kevin Hughes, MD, FACS
Who to Test and What Model Is Best?
Amanda Woodworth, MD, FACS, CPE
Risk Assessment and Post-test Counseling
Jennifer Plichta, MD, MS, FACS
Clinical Guidelines and Prophylaxis Based on Mutations
Ashley Stuckey, MD, FACOG, FACS
Q&A

Closing Remarks